Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains isoflavones (diadzein and genistein) and palmitoylethanolamide (PEA). Isoflavones are plant-derived compounds with potential estrogenic activity, while PEA is an endogenous fatty acid amide involved in pain and inflammation modulation.
## Primary Indications
This combination is primarily marketed as a dietary supplement for:
* Pain management, particularly neuropathic pain and inflammatory conditions.
* Menopausal symptom relief.
* General wellness support.
*Note: These indications are not FDA-approved indications for a drug.*
## Adult Dosing
Dosing varies widely depending on the specific product formulation and intended use. Typical daily doses found in supplements range from:
* **Diadzein:** 20-100 mg
* **Genistein:** 20-100 mg
* **Palmitoylethanolamide (PEA):** 300-1200 mg
These components are often taken together in a single capsule or tablet. Doses may be divided throughout the day. Specific dosing should follow product labeling or healthcare provider guidance.
## Pediatric Dosing
There is **no established pediatric dosing** for this combination product. Use in pediatric populations is not recommended without explicit guidance from a qualified healthcare provider.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are established.
* **Hepatic Impairment:** No specific dose adjustments are established.
## Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding (due to potential hormonal effects of isoflavones).
* Hormone-sensitive cancers (e.g., breast, ovarian, uterine cancer) due to potential estrogenic activity of isoflavones.
## Adverse Effects
Adverse effects are generally mild and uncommon but may include:
* **Gastrointestinal:** Nausea, abdominal discomfort, diarrhea.
* **Hormonal:** Menstrual irregularities, breast tenderness (primarily associated with isoflavones).
* **Allergic reactions:** Rash, itching.
## Key Drug Interactions
* **Hormone Therapies:** Potential additive effects with estrogen therapy or other hormone-modulating agents.
* **Thyroid Medications:** Isoflavones may interfere with thyroid function; caution in patients with thyroid disorders.
* **Anticoagulants/Antiplatelets:** Some isoflavones may have mild antiplatelet effects, though clinical significance is unclear. Monitor for increased bleeding risk.
## Monitoring
* Monitor for gastrointestinal upset or signs of allergic reaction.
* For individuals with a history of hormone-sensitive cancers, monitor for any concerning symptoms.
* For patients with thyroid conditions, consider monitoring thyroid function if significant concerns arise.
## Clinical Pearls
* The efficacy of this combination for its purported indications is largely based on preclinical data and limited clinical studies, primarily for individual components.
* Due to the potential hormonal effects of diadzein and genistein, caution is advised in individuals with a history of hormone-sensitive cancers or those on hormone replacement therapy.
* Palmitoylethanolamide's mechanism of action is still under investigation, but it is thought to act on the endocannabinoid system and mast cells.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information or product labeling before making any decisions regarding drug therapy. Local protocols and individual patient factors may necessitate variations in treatment.*
